Reglagene is a pioneering therapeutics company specializing in the design and development of brain penetrant medicines. Focused on offering innovative therapies, it aims to ensure safe and effective treatment of various brain diseases, contributing significantly to the biotechnology and life sciences fields.
Reglagene belongs to the Biotechnology, Pharmaceuticals and Biotechnology, Biotechnology and Life Sciences industry.
What are the specialties of Reglagene?
Reglagene specializes in Brain penetrant drug development, Tubulin-targeting therapies, Oral administration solutions, Brain cancer treatments, Innovative brain disease therapeutics.
What products and services is Reglagene likely to offer?
Reglagene offers Tubulin-targeting therapies, Brain cancer treatments, Brain penetrant medicines, Therapeutics for brain diseases, Innovative biotechnology solutions.
Who are the competitors of Reglagene?
Competitors of Reglagene are Neurocrine Biosciences, Axovant Gene Therapies, Sorrento Therapeutics, Acorda Therapeutics, Zymeworks, Biogen, Marinus Pharmaceuticals, NantKwest.
What does Reglagene do?
Reglagene is a pioneering therapeutics company specializing in the design and development of brain penetrant medicines. Focused on offering innovative therapies, it aims to ensure safe and effective treatment of various brain diseases, contributing significantly to the biotechnology and life sciences fields.